Polymersome delivery of siRNA and antisense oligonucleotides.
siRNA and antisense oligonucleotides, AON, have similar size and negative charge and are often packaged for in vitro delivery with cationic lipids or polymers-but exposed positive charge is problematic in vivo. Here we demonstrate loading and functional delivery of RNAi and AON with non-ionic, nano-transforming polymersomes. These degradable carriers are taken up passively by cultured cells after which the vesicles transform into micelles that allow endolysosomal escape and delivery of either siRNA into cytosol for mRNA knockdown or else AON into the nucleus for exon skipping within pre-mRNA. Polymersome-mediated knockdown appears as efficient as common cationic-lipid transfection and about half as effective as Lenti-virus after sustained selection. For AON, initial results also show that intramuscular injection into a mouse model of muscular dystrophy leads to the expected protein expression, which occurs along the entire length of muscle. The lack of cationic groups in antisense polymersomes together with initial tests of efficacy suggests broader utility of these non-viral carriers.
Kim
Younghoon
Y
Department of Chemical and Biomolecular Engineering and Pennsylvania Muscle Institute, University of Pennsylvania, Philadelphia, USA.
Tewari
Manorama
M
Pajerowski
J David
JD
Cai
Shenshen
S
Sen
Shamik
S
Williams
Jason H
JH
Williams
Jason
J
Sirsi
Shashank R
SR
Sirsi
Shashank
S
Lutz
Gordon J
GJ
Lutz
Gordon
G
Discher
Dennis E
DE
D000818:Animals; D001672:Biocompatible Materials / Q000008:administration & dosage / Q000737:chemistry; D002460:Cell Line; D002467:Cell Nucleus / Q000737:chemistry; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000737:chemistry; D016189:Dystrophin / Q000235:genetics / Q000378:metabolism; D005786:Gene Expression Regulation; D034882:Lamins / Q000235:genetics / Q000378:metabolism; D051379:Mice; D018101:Mice, Inbred mdx; D018485:Muscle Fibers, Skeletal / Q000166:cytology; D053769:Nanocapsules / Q000008:administration & dosage* / Q000737:chemistry*; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage* / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D034741:RNA, Small Interfering / Q000008:administration & dosage* / Q000235:genetics* / Q000378:metabolism
D001672:Biocompatible Materials; D003692:Delayed-Action Preparations; D016189:Dystrophin; D034882:Lamins; D053769:Nanocapsules; D016376:Oligonucleotides, Antisense; D034741:RNA, Small Interfering